[Hormonal treatment of prostatic hypertrophy with special reference to the usefulness of gestagens].
D000284:Administration, Oral; D000367:Age Factors; D000368:Aged; D000728:Androgens / Q000652:urine; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D007273:Injections, Intramuscular; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D009640:Norethindrone / Q000031:analogs & derivatives / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000209:etiology / Q000652:urine
D000728:Androgens; D004967:Estrogens; D006908:Hydroxyprogesterones; D011372:Progestins; D008525:Medroxyprogesterone; D009640:Norethindrone
Uwagi na temat hormonalnego leczenia przerostu gruczołu krokowego z uwzglednieniem przydatności gestagenów